INTRODUCTION
============

Ossification of the posterior longitudinal ligament (OPLL) has been known as a multifactorial disease \[[@B1],[@B2]\]. The most characteristic symptom of OPLL is myelopathy resulting from the compression of the spinal cord; other signs and symptoms include sensory dysfunction of the upper and the lower extremities, motor weakness, an increased deep tendon reflex, and neurogenic bladder and bowel \[[@B3]\]. Genetic factors are considered to play an important role in the etiology of OPLL based on nationwide pedigree surveys, twins surveys, and human leukocyte antigen (HLA) haplotype analysis \[[@B2],[@B4],[@B5]\]. Recently, the relationship between single-nucleotide polymorphisms (SNPs) in various genes and OPLL has been studied. A case-control association and sib-pair linkage studies have shown that several genes are related to the susceptibility to OPLL. These include genes for collagen, type VI, alpha 1 (COL6A1), collagen, type XI, alpha 2 (COL11A2), bone morphogenetic protein 2 (BMP2), ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), estrogen receptor 1 (ESR1), interleukin-1 beta (IL1B), leptin receptor, and transforming growth factor beta 1 (TGFB1) \[[@B6]-[@B16]\].

In this study, 768 DNA chips were used to investigate whether SNPs of several genes are associated with the occurrence of OPLL, and angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (ACE) was found to have a relationship with susceptibility to OPLL. ACE has a major role in the renin-angiotensin system, and it also inactivates the bradykinin, a vasodilator, in the kallikrein-kinin system \[[@B17]\]. An insertion/deletion (I/D) polymorphism in intron 16 of the *ACE* gene (NCBI, dbSNP database, BUILD 129) was found to be associated with plasma and cellular ACE levels \[[@B18]\], so primers for ACE I/D polymorphism were selected for this study. The ACE I/D polymorphism in OPLL patients has not been reported yet. In this study, we report the association between ACE I/D polymorphism and OPLL in the Korean population.

MATERIALS AND METHODS
=====================

Subjects
--------

This study protocol was approved by the Ethics Committee of the Medical Research Institute, Kyung Hee University Hospital at Gangdong, Korea. This study was conducted on 95 patients with OPLL who visited the outpatient clinic or were hospitalized at The Spine Center at Kyung Hee University Hospital and the Department of Physical Medicine & Rehabilitation of Kyung Hee Medical Center. The OPLL patients were diagnosed by computed tomography, magnetic resonance imaging, and/or radiograph findings. The patients with a spinal operation, other spinal diseases, such as myelopathy, spinal tumor, spinal fracture, were excluded. Healthy control subjects (n=274) with no evidence of OPLL in cervical X-ray were recruited after a general health check-up program confirmed that they had no clinical evidence of any severe diseases, such as stroke, diabetes, myocardial infarction, and psychiatric disorders. The OPLL group consisted of 53 males (61.67±11.39 years) and 42 females (61.14±15.23 years). The control group was comprised of 182 males (58.46±5.89 years) and 92 females (53.3±13.73 years).

DNA samples and genotyping of ACE I/D polymorphism
--------------------------------------------------

Blood samples were obtained from all the participants with informed written consent. Genomic DNA was extracted from blood samples using QIAamp DNA mini kit (QIAGEN, Valencia, CA, USA). Genomic DNA was amplified using the following primers for ACE I/D polymorphism (sense, 5\'-CTGGAGACC ACT CCC ATC CTT TCT-3\'; antisense, 5\'-GAT GTGGCC ATC ACA TTC GTC AGA T-3\'; size, 480 bp). Polymerase chain reaction (PCR) was 35 cycles at 94℃ for 30 seconds, 58℃ for 30 seconds, 72℃ for 1 minute, and 1 cycle at 72℃ for 7 minutes to terminate the reaction. The PCR products were identified with 1.5% agarose gel electrophoresis.

Statistical analysis
--------------------

A statistical analysis was performed using the SPSS software (SPSS Inc., Chicago, IL, USA). The chi-square (χ^2^) test was used to value Hardy-Weinberg equilibrium. A logistic regression analysis controlling age and sex as co-variables in three models (codominant, dominant, and recessive model) was performed using SNPAnalyzer (ISTECH Inc., Goyang, Korea), Helixtree (Golden Helix Inc., Bozeman, MT, USA), and SNPstats (<http://bioinfo.iconcologia.net/index.php>) \[[@B19],[@B20]\]. A p-value less than 0.05 was considered as statistically significant.

RESULTS
=======

In this study, we investigated whether ACE I/D polymorphism is associated with OPLL in the Korean population. We calculated the exact size of the PCR product for genotypes of ACE I/D polymorphism (rs4646994) using NCBI website (<http://www.ncbi.nlm.gov/SNP/>, BUILD 129; ALFRED \[the Allele Frequency Database\], 285-bp Alu). As shown in [Fig. 1](#F1){ref-type="fig"}, the I/D genotype was observed at 480 bp and 195 bp. The deletion homozygote (D/D) and the insertion homozygote (I/I) were observed at 195 bp and 480 bp, respectively.

The genotype and the allelic frequencies of I/D polymorphism of the *ACE* gene in the control subjects and the OPLL patients are shown in [Table 1](#T1){ref-type="table"}. No deviation of Hardy-Weinberg equilibrium was found in the control group. The frequencies of I/I and D/D genotypes were 28.5% and 25.6% in the control group, and 27.4% and 46.3% in the OPLL group, respectively. The frequency of I/D genotype was 46.0% in the control group and 26.3% in the OPLL group. The frequencies of I and D alleles were 51.5% and 48.5% in the control group, and 40.5% and 59.5% in the OPLL group, respectively. There were statistically significant differences in the genotype and the allelic frequencies between the control group and the OPLL group (genotype, p\<0.001; allele, p=0.009) ([Table 1](#T1){ref-type="table"}).

A logistic regression analysis in three models (codominant, dominant, and recessive models) was used for odds ratio (OR), 95% confidence interval (CI), and a corresponding p-value, controlling age and sex as co-variables. In logistic analysis, we found a significant association between ACE I/D polymorphism and OPLL (dominant model; p=0.002; OR, 2.20; 95% CI, 1.33-3.65) ([Table 2](#T2){ref-type="table"}).

DISCUSSION
==========

In this study, we compared the genotype frequencies of ACE I/D polymorphism in 15 intron of the *ACE* gene between the control subjects and the OPLL patients. We found a significant degree of association between ACE I/D polymorphism and OPLL (genotype, p\<0.001; allele, p=0.009) ([Table 1](#T1){ref-type="table"}). Comparing the genotype frequencies in the dominant model (D/D vs. D/I and I/I), we found that the frequency of D/I and I/I in the OPLL group (53.7%) was lower than that in the control group (74.4%), whereas the frequency of D/D in the OPLL group (46.3%) was higher than that in the control group (25.6%). The difference was statistically significant between the OPLL patients and the control subjects (p=0.002; OR, 2.20; 95% CI, 1.33-3.65) ([Table 2](#T2){ref-type="table"}). The result indicates that the D/D genotype of ACE I/D polymorphism may be a risk factor in the development of OPLL in the Korean population.

OPLL is one of the bone-forming diseases, characterized by an ectopic ossification in the spine ligaments \[[@B21],[@B22]\]. Although the etiology of OPLL is not fully defined, genetic background is considered to be a major factor in the development of OPLL. Several studies on the relationship between OPLL and HLA haplotypes in families of the patients with OPLL suggested that genetic factors may play a role in the pathogenesis of OPLL \[[@B2],[@B5]\]. Maeda et al. \[[@B8]\] found a male-specific association of a COL11A2 haplotype with OPLL. Tanaka et al. \[[@B23]\] reported that SNPs in the *COL6A1* gene were strongly associated with OPLL. Plasma ACE levels are associated with the ACE I/D polymorphism \[[@B24],[@B25]\]. Individuals who were homozygous to the D/D genotype showed a high activity of ACE, while those with either I/D or I/I genotype showed a low activity of ACE. Yoshida et al. \[[@B26]\] suggested that homozygote D/D is a risk factor for the progression to a chronic renal failure in IgA nephropathy.

In conclusion, the present study shows the association between ACE I/D polymorphism and OPLL in the Korean population. The frequencies of D/D genotype and D allele in the OPLL patients are higher than those in the control subjects. These results suggest that the deletion polymorphism of the *ACE* gene may be a risk factor for the development of OPLL.
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![Electrophoresis of polymerase chain reaction products of *ACE* gene. Lane 1 is the insertion/deletion heterozygote (I/D). Lane 2 is the insertion homozygote (I/I). Lane 3 is the deletion homozygote (D/D). ACE, angiotensin I converting enzyme.](arm-38-1-g001){#F1}

###### 

Genotype and allele frequencies of *ACE* gene in the control subjects and the patients with OPLL
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Values are presented as number (%).

ACE, angiotensin I converting enzyme; OPLL, ossification of the posterior longitudinal ligament; I/I, insertion/insertion; I/D, insertion/deletion; D/D, deletion/deletion.

^a)^p-value was calculated by chi-square (χ^2^) test using SAS ver. 9.1.

###### 

A logistic regression analysis of *ACE* gene in the control subjects and the patients with OPLL
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Values are presented as number (%).

ACE, angiotensin I converting enzyme; OPLL, ossification of the posterior longitudinal ligament; OR, odds ratio; CI, confidence interval; I/I, insertion/insertion; I/D, insertion/deletion; D/D, deletion/deletion.

^a)^p-values were calculated by a logistic regression analysis with co-dominant, dominant, and recessive models controlling age and gender as covariates.
